GR gene
Our        data suggest that delivery of the GR gene in vivo may reduce inflammation without       recourse to GC and may constitute an alternative therapeutic approach for       corticoresistant asthma.
Our        data suggest that delivery of the  @SUBJECT$  in vivo may  @PREDICAT$   @OBJECT$  without       recourse to GC and may constitute an alternative therapeutic approach for       corticoresistant asthma.